Control Group clinical trials

Explore recruiting control group clinical trials.

Recruiting control group studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Control Group trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PRObiotic Therapy Examining Combinatorial Therapeutics in Multiple Sclerosis - phase II, multicenter, randomised, open-label clinical trial.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Interpectoral-pectoserratus plane block for minimally invasive aortic valve replacement via right anterior minithoracotomy: A single centre, prospective, double-blind, randomized controlled superiority trial

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Statins to Prevent Immune checkpoint inhibitor-induced pRogression of AtheroscLerosis

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A randomized trial of multi-factorial primary prevention in high risk subjects candidate to a lung cancer early detection CT program

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of the safety and efficacy of an advanced therapy medicinal product containing live ASCs in the treatment of diabetic foot syndrome – a double-blind, randomized study.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Cytisine in prolonged dosage versus Nicotine Replacement Therapy in nicotine-dependent patients with Chronic Kidney Disease - single-center, randomized, non-inferiority clinical trial.

Poland

Therapeutic use (Phase IV) EU CTIS Study details

Control Group trials by city

Control Group in Toronto Control Group in Vancouver Control Group in Montreal Control Group in Calgary Control Group in Edmonton Control Group in Ottawa Control Group in Winnipeg Control Group in Quebec City Control Group in Hamilton Control Group in Kitchener Control Group in London Control Group in Halifax Control Group in New York Control Group in Los Angeles Control Group in Chicago Control Group in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease